Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) released its quarterly earnings results on Thursday. Cullinan Therapeutics Stock PerformanceNASDAQ CGEM traded down $0.22 during trading on Friday, hitting $17.73. Cullinan Therapeutics has a 12-month low of $5.68 and a 12-month high of $19.43. Wall Street Zen cut Cullinan Therapeutics from a “hold” rating to a “sell” rating in a research report on Saturday, August 1st. See AlsoReceive News & Ratings for Cullinan Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullinan Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.